NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Trump signs NDAA urging alignment of India’s nuclear liability with global standards, following India’s SHANTI Bill approval for private sector participation.Read More